Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Lymphatic Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Testing effectiveness (Phase 2)WithdrawnNCT02973191
What this trial is testing

Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Celgene
Testing effectiveness (Phase 2)Ended earlyNCT03381118
What this trial is testing

Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
St. Petersburg State Pavlov Medical University 16
Testing effectiveness (Phase 2)Ended earlyNCT03301597
What this trial is testing

NLA101 in Adults Receiving High Dose Chemotherapy for AML

Who this might be right for
Leukemia, Myeloid, Acute
Nohla Therapeutics, Inc. 146
Early research (Phase 1)Study completedNCT01614197
What this trial is testing

A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LymphomaPeripheral T-cell Lymphoma
Therapeutic Advances in Childhood Leukemia Consortium 16
Testing effectiveness (Phase 2)Looking for participantsNCT05194397
What this trial is testing

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

Who this might be right for
Lymphoblastic LeukemiaCancer SurvivorsAplastic Anemia+2 more
Children's Hospital of Philadelphia 80
Not applicableLooking for participantsNCT06535113
What this trial is testing

Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Ciceri Fabio 80
Testing effectiveness (Phase 2)Ended earlyNCT01034410
What this trial is testing

AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Antisoma Research 90
Testing effectiveness (Phase 2)Ended earlyNCT00003113
What this trial is testing

Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma
Case Comprehensive Cancer Center 6
Early research (Phase 1)Looking for participantsNCT06909474
What this trial is testing

Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies

Who this might be right for
T-ALL/Lymphoma
Chongqing Precision Biotech Co., Ltd 15
Testing effectiveness (Phase 2)Study completedNCT00476190
What this trial is testing

ALL Adult Consortium Trial: Adult ALL Trial

Who this might be right for
Acute Lymphoblastic Leukemia
Dana-Farber Cancer Institute 112
Testing effectiveness (Phase 2)Active Not RecruitingNCT06035497
What this trial is testing

Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

Who this might be right for
Relapsed or Refractory T-cell Lymphomas
Bristol-Myers Squibb 85
Early research (Phase 1)Active Not RecruitingNCT01430390
What this trial is testing

In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies

Who this might be right for
Acute Lymphocytic LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 19
Testing effectiveness (Phase 2)Ended earlyNCT06268574
What this trial is testing

Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML

Who this might be right for
Acute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome
Ryvu Therapeutics SA 62
Testing effectiveness (Phase 2)Looking for participantsNCT04068597
What this trial is testing

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Who this might be right for
Haematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more
CellCentric Ltd. 250
Not applicableUnknownNCT01966497
What this trial is testing

Observational Study of Patients Older Than 60 Years With Acute Myeloblastic Leukemia

Who this might be right for
Acute Myeloblastic LeukemiaAged Higher Than 60 Years Old
Assistance Publique - Hôpitaux de Paris 1,000
Not applicableNo Longer AvailableNCT04678466
What this trial is testing

Flotetuzumab Expanded Access Program

Who this might be right for
Acute Myeloid LeukemiaAMLAML, Adult Recurrent
MacroGenics
Not applicableUnknownNCT05873322
What this trial is testing

Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-LymphomaDrug-Induced Diabetes MellitusImpaired Glucose Tolerance+1 more
Aarhus University Hospital 100
Early research (Phase 1)Looking for participantsNCT06634394
What this trial is testing

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Aptevo Therapeutics 39
Not applicableNot Yet RecruitingNCT06763302
What this trial is testing

NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL

Who this might be right for
B Cell Precursor Acute Lymphoblastic LeukemiaPediatricMinimal Residual Disease+1 more
The Children's Hospital of Zhejiang University School of Medicine 1,220
Next Page